Our Experience With Sacubitril/Valsartan in Chronic Heart Failure Management - HFrEF in the Ambulatory Setting

BACKGROUND: The prevalence of chronic heart failure (CHF) is up to 1-2% of the adult population in developed countries, rising to >10% after the age of 70. Heart failure with reduced ejection fraction (HFrEF) remains a prevalent clinical syndrome associated with significant morbidity and mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Naser, Nabil, Kulić, Mehmed, Jatić, Zaim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233466/
https://www.ncbi.nlm.nih.gov/pubmed/35774049
http://dx.doi.org/10.5455/medarh.2022.76.101-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233466/
https://www.ncbi.nlm.nih.gov/pubmed/35774049
http://dx.doi.org/10.5455/medarh.2022.76.101-107

Ejemplares similares